NOV 14, 2019

Clinical Diagnostics & Research 2019

The 2019 Clinical Diagnostics and Research Virtual Event is now available On Demand! This years event brings together clinicians, researchers, medical experts and professionals for the tenth year in a row, elevating the level of collaboration and in turn, advancing clinical diagnostics, research and medicine.

Thousands will join in discussion of the continuous progress made with advances in laboratory testing and patient care and treatment. With new technologies and treatments available, updates in regulatory processes are also necessary to ensure patient safety and proper practices. This complimentary conference offers an amazing opportunity to benefit from interacting with a global community of like-minded colleagues from the comfort of home.

This years event includes the following tracks and topics:

  • Emerging Technologies
    • Digital Lab
    • Artificial Intelligence
    • Sustainability
  • Opioid Crisis
    • Epidemiology
    • Non-Opioid Alternative
    • Treatments for Pain Management
    • Monitoring Patients' Opioid Use via Urinalysis and other Mediums
  • Regulatory
    • Proficiency testing for HgA1c
    • Impact of PAMA
  • Clinical Lab Value
    • TDM for Biologics
    • Sepsis Management
    • Laboratory Stewardship

Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open 6 months from the date of the live event.  The webinars will be available for unlimited on-demand viewing.  This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.

Continuing Education

 

LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 14 credits.

Use #LRclinical to follow the conversation!


Speakers
  • Supervisor of Chemistry & Toxicology, Lake County Crime Laboratory
  • Global Product Manager, Oncology & Precision Diagnostics, QIAGEN
  • Head of Cytogenomics and Laboratory Director, Perkin Elmer Genomics
  • Corresponding member of IFCC C-MHBLM, North Sector POCT Medical Lead, Alberta Public Laboratories, Associate Clinical Professor of Laboratory Medicine, University of Alberta
  • Director Washington Health Professional Services, Nursing Care Quality Assurance Commission, Washington State Department of Health
  • Staff Software Engineer, Qiagen
  • Professor, Head of the Department of Clinical Biochemistry, Cliniques Universitaires Saint Luc
  • Medical Director & Co-Chair, Enterprise Laboratory Stewardship Committee, Enterprise Medical Operations, & Director of Microbiology, Virology, Mycology & Parasitology, Clevelaland Clinic
  • Director of Clinical Chemistry, Special Chemistry/Toxicology, Point-of-Care Testing, and SARC Sections, Pathology and Laboratory Medicine, University of California, Davis, School of Medicine
  • Kliniekhoofd Endocrinologie - Diabetologie, University Hospital Brussels
  • Head of Clinical Biochemistry, Sunnybrook Health Sciences Centre, and Associate Professor, Faculty of Medicine, University of Toronto

Show Resources
Agenda
  • NOV 14, 2019 06:00 AM PST
    Future Directions of Sepsis Management: The Emergence of Artificial Intelligence and the Laboratory Diagnostic Ecosystem
    Speaker: Nam Tran, PhD, HCLD (ABB), FACB
  • NOV 14, 2019 06:00 AM PST
    High Resolution View of D4Z4 Repeat Regions for Studying Facioscapulohumeral Muscular Dystrophy (FSHD) Using Whole Genome Optical Mapping
    Speaker: Alka Chaubey, PhD, FACMG
    Sponsored By: Bionano Genomics
  • NOV 14, 2019 07:30 AM PST
    Keynote Presentation: The Opioid Epidemic in Ohio - A Crime Laboratory Perspective
    Speaker: Douglas Rohde, MS, F-ABC, MLT(ASCP)
  • NOV 14, 2019 09:00 AM PST
    Discovering latent knowledge by applying machine learning techniques to QIAGEN resources
    Speaker: Jeff Green
    Sponsored By: QIAGEN
  • NOV 14, 2019 09:00 AM PST
    Drug testing in Regulatory Monitoring
    Speaker: John Furman, PhD, MSN, COHN-S
  • NOV 14, 2019 09:00 AM PST
    The Role of Proficiency Testing in Achieving Global Outcomes for Hemoglobin A1c
    Speaker: Paul Yip, PhD, FCACB, DABCC
  • NOV 14, 2019 10:30 AM PST
    Identifying the PIK3CA mutations that make a difference in breast cancer with the QIAGEN therascreen® PIK3CA RGQ PCR Kit
    Speaker: Benjamin Chaffey, PhD
    Sponsored By: QIAGEN
  • NOV 14, 2019 10:30 AM PST
    Interferences with thyroid function tests and patient safety
    Speaker: Damien Gruson, PhD
  • NOV 14, 2019 12:00 PM PST
    Panel Discussion: Emerging technologies in laboratory medicine, opportunities and challenges
    Anna Fuezery, PhD, DABCC, FCACB
    Corresponding member of IFCC C-MHBLM, North Sector POCT...
    Damien Gruson, PhD
    Professor, Head of the Department of Clinical Biochemis...
  • NOV 14, 2019 12:00 PM PST
    Thyroid autoimmunity and female infertility
    Speaker: David Unuane, MD, PhD
  • NOV 14, 2019 01:30 PM PST
    Strategies to Improve Laboratory Stewardship
    Speaker: Gary Procop, MD, MS
  • Clinical Lab Value
  • NOV 14, 2019 06:00 AM PST
    Future Directions of Sepsis Management: The Emergence of Artificial Intelligence and the Laboratory Diagnostic Ecosystem
    Speaker: Nam Tran, PhD, HCLD (ABB), FACB
  • NOV 14, 2019 09:00 AM PST
    Drug testing in Regulatory Monitoring
    Speaker: John Furman, PhD, MSN, COHN-S
  • NOV 14, 2019 10:30 AM PST
    Interferences with thyroid function tests and patient safety
    Speaker: Damien Gruson, PhD
  • NOV 14, 2019 12:00 PM PST
    Thyroid autoimmunity and female infertility
    Speaker: David Unuane, MD, PhD
  • NOV 14, 2019 01:30 PM PST
    Strategies to Improve Laboratory Stewardship
    Speaker: Gary Procop, MD, MS
  • Emerging Technologies
  • NOV 14, 2019 06:00 AM PST
    High Resolution View of D4Z4 Repeat Regions for Studying Facioscapulohumeral Muscular Dystrophy (FSHD) Using Whole Genome Optical Mapping
    Speaker: Alka Chaubey, PhD, FACMG
    Sponsored By: Bionano Genomics
  • NOV 14, 2019 09:00 AM PST
    Discovering latent knowledge by applying machine learning techniques to QIAGEN resources
    Speaker: Jeff Green
    Sponsored By: QIAGEN
  • NOV 14, 2019 10:30 AM PST
    Identifying the PIK3CA mutations that make a difference in breast cancer with the QIAGEN therascreen® PIK3CA RGQ PCR Kit
    Speaker: Benjamin Chaffey, PhD
    Sponsored By: QIAGEN
  • NOV 14, 2019 12:00 PM PST
    Panel Discussion: Emerging technologies in laboratory medicine, opportunities and challenges
    Anna Fuezery, PhD, DABCC, FCACB
    Corresponding member of IFCC C-MHBLM, North Sector POCT...
    Damien Gruson, PhD
    Professor, Head of the Department of Clinical Biochemis...
  • Opioid Crisis
  • NOV 14, 2019 07:30 AM PST
    Keynote Presentation: The Opioid Epidemic in Ohio - A Crime Laboratory Perspective
    Speaker: Douglas Rohde, MS, F-ABC, MLT(ASCP)
  • Regulatory
  • NOV 14, 2019 09:00 AM PST
    The Role of Proficiency Testing in Achieving Global Outcomes for Hemoglobin A1c
    Speaker: Paul Yip, PhD, FCACB, DABCC
Speakers

  • Douglas Rohde, MS, F-ABC, MLT(ASCP)
    Supervisor of Chemistry & Toxicology, Lake County Crime Laboratory
    Biography
      Douglas E. Rohde has been employed by the Lake County Crime Laboratory (OH) since January 2000 and serves as the Supervisor of Chemistry and Toxicology. He holds a BS in Chemistry from Gannon University and a MS in Chemistry (Clinical) from Cleveland State University. Prior to his current position, he was employed in the Department of Pathology and Laboratory Medicine at the Cleveland Clinic Foundation for 12 years and began his career in 1983 performing toxicology testing for the Erie County Coroner (PA). He has provided expert testimony/opinion reports in the areas of controlled substance/poison identification and toxicology analysis/impairment in several counties in Ohio and Pennsylvania. He is a Fellow (Toxicology Section) of the American Academy of Forensic Sciences, a member of the Society of Forensic Toxicologists and The International Association of Forensic Toxicologists and holds board certification from the American Board of Criminalistics and the American Society for Clinical Pathology. He is a member of the National Safety Council - Alcohol, Drugs and Impairment Division and has served as an adjunct instructor at Cleveland State University, John Carroll University, Ohio Northern University and Lake Erie College.
    • Benjamin Chaffey, PhD
      Global Product Manager, Oncology & Precision Diagnostics, QIAGEN
      Biography
        Ben is a member of the Oncology Diagnostics Global Product Management team at QIAGEN, with responsibility for commercialisation of innovative new Companion Diagnostic tests around the world, including the therascreen FGFR RGQ RT-PCR Kit recently approved by the FDA in the USA. A molecular biologist and immunologist by qualification, he has over a decade of experience in the IVD industry covering a range of roles including assay development, manufacturing and product management. He is based in Manchester, UK, the QIAGEN global centre of excellence for companion diagnostic development, where the FGFR RGQ RT-PCR Kit was originally developed.
      • Alka Chaubey, PhD, FACMG
        Head of Cytogenomics and Laboratory Director, Perkin Elmer Genomics
        Biography
          Dr. Chaubey is an ABMGG-board certified diplomate in clinical cytogenetics/genomics and clinical molecular genetics/genomics. She is also a fellow of the American College of Medical Genetics and Genomics (FACMG). Previously, Dr. Chaubey was the Director of the Cytogenomics Laboratory at Greenwood Genetic Center. She received her Doctorate degree (PhD) from Guru Nanak Dev University, Amritsar, India and completed her post-doctoral studies at Center for Cellular and Molecular Biology (CCMB), Hyderabad, India and University of Illinois at Chicago (UIC).
        • Anna Fuezery, PhD, DABCC, FCACB
          Corresponding member of IFCC C-MHBLM, North Sector POCT Medical Lead, Alberta Public Laboratories, Associate Clinical Professor of Laboratory Medicine, University of Alberta
          Biography
            Anna Füzéry obtained her PhD in biochemistry from the University of Wisconsin-Madison, and subsequently completed a 2-year postdoctoral training program in clinical chemistry at Johns Hopkins Medical Institutes in Baltimore, MD. She accepted a position as clinical chemist for Alberta Health Services in 2013, where she oversaw high volume general chemistry testing at 11 laboratories in Edmonton, Alberta. She became medical lead of point-of-care testing (POCT) for Edmonton in 2017, and for the northern half of the province of Alberta in 2019. Her current interest is in enabling high quality, clinically relevant POCT in mobile health environments.
          • John Furman, PhD, MSN, COHN-S
            Director Washington Health Professional Services, Nursing Care Quality Assurance Commission, Washington State Department of Health
            Biography
              Dr. Furman is the Director of Washington State Health Professional Services (WHPS). WHPS is the state approved Alternative to Discipline substance use monitoring program for the nursing professions. He has worked for the state of Washington for 40 years primarily in the areas of behavioral and occupational health. Educational background includes undergraduate and graduate degrees in nursing, doctorate in health administration, and certification as an occupational health nurse-specialist. Dr. Furman has been involved in the promotion of healthcare safety for many years serving as the president of the Pacific Northwest Chapter of the Association of Occupational Health Professionals (AOHP), vice-president of the Puget Sound Chapter of the Association of Professionals in Infection Control, and vice-president of the Washington Healthcare Safety Council (WHCSC). In addition he has completed two appointments on the National Organization of Alternative Programs (NOAP) Executive Committee, and currently serves on the Journal of Occupational Health Professionals (AOHP) editorial committee. Prior to coming to WHPS Dr. Furman worked with the Department of Labor & Industries Division of Occupational Safety and Health (DOSH). Where he helped develop nationally recognized programs on pesticide exposure monitoring, and outdoor heat exposure. Just prior to leaving the DOSH program he acted as the primary author of the nation's first Healthcare Hazardous Drug Exposure regulation.
            • Jeff Green
              Staff Software Engineer, Qiagen
              Biography
                Jeff Green is the primary architect for Ingenuity Pathway Analysis (IPA) and leads a cross-functional team at QIAGEN to apply machine learning to curated content.
              • Damien Gruson, PhD
                Professor, Head of the Department of Clinical Biochemistry, Cliniques Universitaires Saint Luc
                Biography
                  Professor Damien Gruson was awarded his degree of Pharmacist and later of Specialist in Laboratory Medicine from the Catholic University of Louvain, Brussels, Belgium. He is the head of the department of Clinical Biochemistry of the Cliniques Universitaires Saint Luc. He is also member of the research unit on Endocrinology Diabetes and Nutrition of the Catholic University of Louvain. Pr. D. Gruson has published numerous articles in several international peer-reviewed journals. Pr. D. Gruson is member of the division on Emerging Technology of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Pr. D. Gruson is also Fellow of the European Society of Cardiology.
                • Gary Procop, MD, MS
                  Medical Director & Co-Chair, Enterprise Laboratory Stewardship Committee, Enterprise Medical Operations, & Director of Microbiology, Virology, Mycology & Parasitology, Clevelaland Clinic
                  Biography
                    Gary W. Procop, MD, MS is Medical Director and Co-Chair of the Enterprise Laboratory Stewardship Committee for Enterprise Medical Operations. He is the Director of Molecular Microbiology, Virology, Mycology and Parasitology at the Cleveland Clinic. He is past Chair of the Departments of Clinical Pathology and Molecular Pathology, and past Section Head for Clinical and Molecular Microbiology. He completed a Bachelor of Science at Eastern Michigan University, followed by an M.D. and M.S. at Marshall University School of Medicine. Residency training in Anatomic and Clinical Pathology training was completed at Duke University Medical Center and a Clinical Microbiology Fellowship at the Mayo Clinic. He is a diplomat of the American Board of Pathology in Anatomic and Clinical Pathology, and Medical Microbiology. He is a Fellow of the American Academy of Microbiology, the College of American Pathologists, the American Society for Clinical Pathology, the Infectious Diseases Society of America, and the Royal Society of Tropical Medicine and Hygiene. He has given more than 670 scientific presentations, and has 218 published manuscripts, 50 chapters, and three books to his credit. He is the former Chair of the Committee on Continuing Certification (3C), member of the Accountability & Resolution Committee, and a Member of the Board of Directors of the American Board of Medical Specialties. He is a former Chair of the Microbiology Test Development Committee, a Past President, former Trustee and is currently an ex officio of the American Board of Pathology. He is Member of the Board of Directors and the Chair of the Antifungal Subcommittee of the Clinical Laboratory Standards Institute. He is a member of the Board of Directors of the American Society for Clinical Pathology, the Chair of the Commission on Science, Technology and Policy, and a Member of the Effective Test Utilization Subcommittee of this Commission. He is also a former Member of the Council on Scientific Affairs, former Chair of the Microbiology Resource Committee and is a current member of the Quality Practices Committee for the College of American Pathologists. He has served as a Member of the NGS Coalition and Conferences Committee for the American Society for Microbiology. Major recognitions include the ASM BD Award for Research in Clinical Microbiology, the CAP Distinguished Patient Care Award, the Cleveland Clinic John Beach Hazard Teaching Award, the ASCP Mastership Designation, and the Belinda Yen-Lieberman, PhD, and James M. Lieberman, MD, Endowed Chair in Clinical Microbiology. His primary interests are developing and promoting best practices in laboratory testing, the practical applications of molecular diagnostic methods for the diagnosis and treatment of infections; infectious disease pathology; mycology and parasitology. He is currently working on a Masters of Education in Health Professions through Johns Hopkins University.
                  • Nam Tran, PhD, HCLD (ABB), FACB
                    Director of Clinical Chemistry, Special Chemistry/Toxicology, Point-of-Care Testing, and SARC Sections, Pathology and Laboratory Medicine, University of California, Davis, School of Medicine
                    Biography
                      Dr. Tran is Associate Professor at the University of California, Davis School of Medicine in the Department of Pathology and Laboratory Medicine. He completed his doctoral training (PhD) at UC Davis in 2008. Thereafter, Dr. Tran completed a postdoctoral training scholarship under the National Institutes of Biomedical Imaging and Bioengineering funded Point-of-Care Technologies Center at UC Davis - focusing on the development of point-of-care molecular pathogen detection systems for critical, emergency, and disaster settings. In 2009, he was awarded a $1.8M Department of Defense grant to determine the clinical impact of near patient molecular pathogen detection in burn sepsis patients. Presently, Dr. Tran is a Board-Certified Clinical Chemist, and serves as and Director of Clinical Chemistry, Special Chemistry/Toxicology, and Point-of-Care Testing at UC Davis Health. His work has expanded to involve artificial intelligence and machine learning for acute kidney injury and sepsis in at risk populations.
                    • David Unuane, MD, PhD
                      Kliniekhoofd Endocrinologie - Diabetologie, University Hospital Brussels
                      Biography
                        David Unuane is a member of staff at the department of endocrinology and diabetology at the University Hospital Brussels (UZ Brussel, VUB) where he is working as a consultant and clinical professor. He received his medical degree from the Free University Brussels- Vrije Universiteit Brussel (VUB), Brussels, Belgium. Professor Unuane has been involved in clinical research as endocrinologist and PhD student since 2008. He has a special interest in endocrine disorders and female infertility. In 2017, he obtained his PhD degree in medical sciences on the topic of female infertility and the role of thyroid autoimmunity in assisted reproductive technology. He is a current board member of the Belgian thyroid club and has served as referee in various medical journals such as human reproduction.
                      • Paul Yip, PhD, FCACB, DABCC
                        Head of Clinical Biochemistry, Sunnybrook Health Sciences Centre, and Associate Professor, Faculty of Medicine, University of Toronto
                        Biography
                          Dr. Paul Yip is Division Head of Clinical Biochemistry at Sunnybrook Health Sciences Center in Toronto, and is Associate Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. Prior to his current position, he was at University Health Network (UHN) in Toronto as a Clinical Biochemist for 12 years. Dr. Yip is a diplomate of the American Board of Clinical Chemistry (DABCC) and a Fellow of the Canadian Academy of Clinical Biochemistry (FCACB). He has served in various leadership positions including Chair of the Chemistry Scientific Committee of the Institute of Quality Management in Healthcare (IQMH), and is past Chair of the Upstate New York Section of the American Association for Clinical Chemistry (AACC). Dr. Yip's professional interests are in the areas of test utilization, laboratory quality management and point-of-care testing. He is passionate about education at all levels of learning, and also the recipient of the Canadian Society of Clinical Chemists (CSCC) Award for Education Excellence in 2018. Dr. Yip has authored over 140 journal articles, book chapters, and abstracts.
                        Sponsored By

                        For information on becoming a sponsor or exhibitor, please click here.


                        Posters

                        POSTER SUBMISSION GUIDELINES

                        Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.


                        SUBMIT YOUR ABSTRACT

                        Enter the following information to this Submission Form:

                        • Poster Title
                        • Your Name
                        • Your Institution
                        • Your Email
                        • Abstract describing the poster


                        All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

                        If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

                        Questions? Email Posters@LabRoots.com

                        LabRoots Policy

                        C.E. Credits

                        The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                        Committee

                        To download the Program Committee brochure here.


                        • Sihe Wang

                          Dr. Sihe Wang is Section Head and Medical Director of Clinical Biochemistry and Director of Clinical Biochemistry Fellowship Training Program, Cleveland Clinic, Cleveland, Ohio. He also chairs the clinical chemistry integration effort for the Cleveland Clinic Health System which ...

                          See more See less
                        • Gary Garrety

                          Gary Garrety is the Operations Manager for the Prescription Monitoring Program at the Washington State Department of Health. In his ten years of government service for the state of Washington he's worked to support health professionals struggling with substance misuse issues ...

                          See more See less
                        • Damien Gruson

                          Professor Damien Gruson was awarded his degree of Pharmacist and later of Specialist in Laboratory Medicine from the Catholic University of Louvain, Brussels, Belgium. He is the head of the department of Clinical Biochemistry of the Cliniques Universitaires Saint Luc. He is also ...

                          See more See less
                        • Brian McNally

                          Brian McNally received his doctorate in Cell & Molecular Biology at University of Texas Southwestern Medical Center, where he focused on the transcriptional mechanisms governing polycystic kidney disease, renal cancer and development. His post-doctoral fellowship concentrated on ...

                          See more See less
                        Help

                        General LabRoots Questions

                        For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                        Contact us

                        Virtual Events and Webinars

                        Supported Configurations

                        • Operating System Internet Explorer Firefox Chrome Safari
                          Vista IE8+ FF10+ Chrome15+
                          Windows 7 IE8+ FF10+ Chrome15+
                          Windows 8 IE10 FF10+ Chrome15+
                          Mac OS X   FF10+ Chrome15+ Safari5.1+
                        • Cookie settings: session cookies enabled
                        • Browser configuration must have JavaScript enabled
                        • Adobe Flash player 10.2 or later

                        To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                        Internet Connection

                        • A minimum of 100Kbps is recommended for audio-only events
                        • A minimum of 300Kbps is recommended for speaker on-video events

                        Computer Equipment

                        • Screen Resolution: Minimum 1024x768
                        • Video Card: 65,000 colors minimum
                        • Sound card and speakers (or headphones) for hearing webcast in full format
                        • Audio Card: 16-bit minimum
                        • RAM: 512MB of free RAM

                        Firewall Protocol

                        • HTTP on port 80 or HTTPS on port 443
                        • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                        • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                        Work-At-Home Attendees

                        • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                        For A Seamless Experience

                        When using a mobile device, FREE Mobile Apps are available:

                        - For viewing Webinars:

                        - For viewing Virtual Events

                        Attendee Guide

                        • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                        Virtual Event and Webinar Support:

                        Continuing Education (CME/CE) Support

                        Show Resources